In the following video, Motley Fool health-care analyst David Williamson discusses Dendreon's (NASDAQ: DNDN) strong quarterly results that included top-line growth. Dendreon announced preliminary results in early January, so many of the numbers weren't big news, but David takes investors through key takeaways from the conference call, including progress on Dendreon's restructuring, its surprising forecast for the current quarter, and why management thinks the future is bright.
